Aug 08, 2024 / 08:30PM GMT
Operator
Thank you for standing by. My name is Meg, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2024 Xenon Pharmaceuticals, Inc. earnings conference call. (Operator Instructions) Thank you. I would now like to turn the conference over to Mr. Chad Fugere, VP, IR for Xenon. Please go ahead.
Chad Fugere - Xenon Pharmaceuticals Inc - IR
Good afternoon. Thank you for joining us on our call and webcast to discussXenon's second quarter 2024 financial and operating results.Joining me today are Ian Mortimer, Xenon's President and Chief Executive Officer; Dr. Chris Kenney, Xenon's Chief Medical Officer; and Sherry Aulin, Xenon's Chief Financial Officer; along with Dr. Chris Von Seggern, Xenon's Chief Commercial Officer, who will be available during the Q&A period.
Ian we'll begin with a summary of our recent progress across our business, including a summary of our expanding preclinical pipeline programs, and Chris Kenney will provide an overview of our ongoing clinical stage programs including our plans in
Q2 2024 Xenon Pharmaceuticals Inc Earnings Call Transcript
Aug 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers